csonnier
J.P. Morgan Healthcare Conference 2023 Transcript
Transcription may have some errors – apologize in advance Paul Edick – I would remind everyone to pay attention to our forward looking statements. Investing is always a risk. We’ll start out with an overview of the company. Xeris has a very diversified revenue base. We have three marketed assets, all growing record level. I’ll…
Q1 2022 Earning Call Audio & Transcription
Transcription is computer automated and may not be 100% accurate, but until Seeking Alpha provides their transcript, this is better than nothing. Once Seeking Alpha provides the call transcript, this automated transcription will be removed. Updated with Seeking Alpha transcript: Source Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30…
Q4 2021 Earning Call Audio & Transcription
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2021 Earnings Conference Call March 10, 2022 8:30 AM ET Company Participants Allison Wey – SVP, IR and Corporate Communications Paul Edick – Chairman and CEO Steve Pieper – CFO Conference Call Participants Roanna Ruiz – SVB Leerink Vamil Divan – Mizuho Securities David Amsellem – Piper Sandler Operator Hello everyone….
Fireside Chat with Paul Edick – Xeris Biopharma – $XERS
Fireside chat with Paul Edick – CEO of Xeris Biopharma – $XERS
What Lies Ahead For Xeris Biopharma In 2022
Jan. 1 PDUFA for Recorlev, Merck collaboration, Levothyroxine Phase 1, EIH Phase 2, and growing sales for Gvoke and Keveyis; Xeris has great potential for 2022.
2021 Q3 Earnings Call Recording
Transcription is computer automated and may not be 100% accurate, but until Seeking Alpha provides their transcript, this is better than nothing. Once Seeking Alpha provides the call transcript, this automated transcription will be removed. Edit: Transcription has been updated using Seeking Alpha | Source Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2021 Earnings Conference Call November 10,…
September 2021 Corporate Presentation Preview
These slides were part of the H.C. Wainwright 23rd Annual Global Investment Conference presentation which appear to be pages from the upcoming September 2021 Corporate Presentation.
BlackRock Form 8.3s
Source
$XERS – Ideal time to jump in
Source: r/pennystocks • Posted by u/ValterUdarnik • Original Post May you all be greeted fellow pennystockerians, today I want to remind you about XERIS, a commercial-stage pharma company which specializes in ready-to-use, liquid-stable injectables. I will present you some general information first to grasp the potential and after that the financial situation. Feel free to skip the parts…